Trial NCT03122548

View at ClinicalTrials.gov 
Org. Study IDs: ADU-CL-14
Secondary IDs: KEYNOTE KN-463

Last trial update was posted on 2019-04-04

MeSH Interventions

Pembrolizumab

MeSH Conditions

Adenocarcinoma Esophageal Neoplasms

Other Conditions

Esophageal Adenocarcinoma Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Stopping Reasons

Low enrollment and lack of clinical activity in other CRS-207 studies.

Limitations And Caveats

Study was terminated early and included a small number of subjects, and insufficient data were available to evaluate the clinical activity of the study treatment. Due to low enrollment, some protocol-specified outcome measures were not evaluated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID